- Home
- CTXR vs MPU Comparison
CTXR vs MPU Comparison
Compare CTXR & MPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTXR
- MPU
- Stock Information
- Founded
- CTXR 2007
- MPU 1989
- Country
- CTXR United States
- MPU Singapore
- Employees
- CTXR N/A
- MPU N/A
- Industry
- CTXR Biotechnology: Pharmaceutical Preparations
- MPU Transportation Services
- Sector
- CTXR Health Care
- MPU Consumer Discretionary
- Exchange
- CTXR Nasdaq
- MPU Nasdaq
- Market Cap
- CTXR 84.9M
- MPU 77.9M
- IPO Year
- CTXR N/A
- MPU 1998
- Fundamental
- Price
- CTXR $0.20
- MPU $1.63
- Analyst Decision
- CTXR Strong Buy
- MPU
- Analyst Count
- CTXR 2
- MPU 0
- Target Price
- CTXR $5.00
- MPU N/A
- AVG Volume (30 Days)
- CTXR 2.0M
- MPU 114.6K
- Earning Date
- CTXR 12-27-2024
- MPU 11-12-2024
- Dividend Yield
- CTXR N/A
- MPU N/A
- EPS Growth
- CTXR N/A
- MPU N/A
- EPS
- CTXR N/A
- MPU N/A
- Revenue
- CTXR N/A
- MPU $25,996,600.00
- Revenue This Year
- CTXR N/A
- MPU N/A
- Revenue Next Year
- CTXR N/A
- MPU N/A
- P/E Ratio
- CTXR N/A
- MPU N/A
- Revenue Growth
- CTXR N/A
- MPU 419200.00
- 52 Week Low
- CTXR $0.19
- MPU $0.77
- 52 Week High
- CTXR $1.07
- MPU $4.48
- Technical
- Relative Strength Index (RSI)
- CTXR 29.06
- MPU 57.44
- Support Level
- CTXR $0.31
- MPU $1.47
- Resistance Level
- CTXR $0.51
- MPU $1.84
- Average True Range (ATR)
- CTXR 0.06
- MPU 0.17
- MACD
- CTXR -0.01
- MPU 0.01
- Stochastic Oscillator
- CTXR 3.83
- MPU 57.14
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.
About MPU Mega Matrix Corp.
Mega Matrix Corp is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment.